Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EOM: Myopia Intervention in Preschoolers
NCT07176949Recruiting
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of NVK002 in myopia (4 arms). Primary endpoint: Changes in cycloplegic spherical equivalence at 2 years. Started Jun 2025; status: recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07176949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07176949.